Quantum chemical calculations of Warfarin sodium, Warfarin and its metabolites

Communications in Computational Physics

Volumn 4, Issue 1, 2008, Pages 161-176

  Tekin, Emine Deniz ^a   Erkoç, Figene ^b   Yildiz, Ilkay ^c   Erkoç, Şakir ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Ab initio calculation; Density functional method; Warfarin Semi empirical method

Indexed keywords

EID: 50049084080     PISSN: 18152406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. R. Kimura, K. Miyashita, Y. Kokubo, Y. Akaiwa, R. Otsubo, K. Nagatsuka, T. Otsuki, A. Okayama, K. Minematsu, H. Naritomi, S. Honda, H. Tomoike, T. Miyata, (2007), Genotypes of vitamin K epoxide reductase, -glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients, Throm. Res., 120: 181-186.
2. A. Dolmella, S. Gatto, E. Girardi, G. Bandoli, (1999), X-ray structures of the anticoagulants coumatetralyl and chlorophacinone. Theoretical calculations and SAR investigations on thirteen anticoagulant rodenticides, J. Mol. Struct., 513: 177-199.
3. M.Gebauer, (2007), Synthesis and structure-activity relationships of novel warfarin derivatives, Bioorg. Med. Chem., 15: 2414-2420.
4. C.W. Locuson and J. L. Wahlstrom, (2005), Three-dimensional quantitative structure- activity relationship analysis of cytochromes p450: Effect of incorporating higher affinity ligands and potential new applications, Drug Metab. Dispos., 33: 873-878.
5. U. Burkert, N.L. Allinger, (1982), "Molecular Mechanics", ACS Monograph 177, Washington.
6. 2 torsional terms, J. Am. Chem. Soc., 99: 8127-8134.
7. J.J.P. Stewart, (1990), MOPAC: A semiempirical molecular orbital program, J. Comp. Aided Molec. Design, 4: 1-105.
8. M.S.J. Dewar, E.G.Zoebisch, E.F. Healy, J.J.P. Stewart, (1985), AM1: A new general purpose quantum mechanical molecular model, J. Am. Chem. Soc., 107: 3902-3909.
9. C.C. Roothaan, (1951), New developments in Molecular orbital theory, Rev. Mod. Phys.,23: 69-89.
10. Hypercube, Inc., (2002), Gainesville, FL, USA.
11. W. Kohn, L.J. Sham, (1965), Self-consistent equations including exchange and correlation effects, Phys. Rev., 140: A1133-A1138.
12. A.D. Becke, (1993), Density-functional thermochemistry. III. The role of exact exchange, J. Chem. Phys. 98: 5648-5652.
13. C. Lee, W. Yang and R.G. Parr, (1988), Development of the Colle-Salvetti correlation- energy formula into a functional of the electron density, Phys. Rev. B, 37: 785-789.
14. B. Miehlich, A. Savin, H. Stoll and H. Preuss, (1988), Results obtained with the correlation energy density functionals of Becke and Lee, Yang and Parr, Chem. Phys. Lett., 157: 200-206.
15. W. J. Hehre, R. Ditchfield, and J. A. Pople, (1972), Self-Consistent molecular orbital methods. XII. further extensions of gaussian-type basis sets for use in molecular orbital studies of organic molecules, J. Chem. Phys., 56: 2257-2261.
16. M. S. Gordon, (1980), The isomers of silacyclopropane, Chem. Phys. Lett., 76: 163-168.
17. M. J. Frisch, et al., (2003), GAUSSIAN, Revision B.04, Gaussian, Inc., Pittsburgh, PA.
18. P, Fletcher,( 2000), Practical methods of optimization, Wiley-VCH, Weinheim.
19. http://cameron.ni.utoledo.edu:8080/pubhcations_files/ Yanfang%20Li%20spie.pdf
20. http://jchemed.chem.wisc.edu/JCEWWW/Articles/WWW0001/index.html
21. I. Fleming, Frontier Orbitals and Organic Chemical Reactions, John Wiley and Sons, New York, 1976.
22. 14-warfarin sodium by the rat, J. Pharmacol. Exp. Therap.,171: 307-313.
23. L.B. Kier and L.H. Hall, (1999), Molecular Structure Description: The Electrotopological State, Academic Press, San Diego.
24. H. Kubinyi, (1993), QSAR: Hansch Analysis and Related Approaches, VCH Verlagsgesellschaft mbH, Weinheim.
25. S. Lal, S.R. Jada, X. Xiang, W.-T. Lim, E.J.D. Lee, B. Chowbay, (2006), Pharmacogenetics of target genes across the warfarin Pharmacol., Pathway Clin. Pharmacokinet., 45: 1189-1200.
26. P. J. Davis and J. D. Rizzo, (1982), Microbial transformations of warfarin: Stereoselective reduction by Nocardia corallina and Arthrobacter species, Appl. Environ. Microbiol., 43(4): 884-890.
27. Q. Zhou, W.-P. Yau, E. Chan, (2003), Enantioseparation of warfarin and its metabolites by capillary zone electrophoresis, Electrophoresis, 24: 2617-2626.
28. J. Ryman, M. Frick, V. Frykman, M. Rosenqvist, (2003), Duration of warfarin sodium therapy prior to electrical cardioversion of atrial fibrillation, J. Int. Med., 253: 76-80.
29. T.D. Szucs and M.Bramkamp, (2006), Pharmacoeconomics of anticoagulation therapy for stroke prevention in atrial fibrillation: a review, J. Throm. Haemos., 4: 1180-1185.
30. A.D. Weinberg, J.S. Altman, J.K. Pals, (2006), Quality improvement case study: Warfarin sodium interactions, J. Am. Med. Dir. Assoc., 7: 315-318.
31. http://www.fda.gov/cder/Offices/ODS/MG/warfarin-MG.pdf
32. L. Turner, (2006), Keeping warfarin therapy in balance, Nursing2006, November: 43-45.
33. R. Lombardi, V. Chantarangkul, M. Cattaneo, A. Tripodi, (2003), Measurement of warfarin in plasma by high performance liquid chromatography (HPLC) and its correlation with the international normalized ratio, Throm. Res., 111: 281-284.
34. Manolov, C. Maichle-Moessmer, N. Danchev, (2006), Synthesis, structure, toxicological and pharmacological investigations of 4-hydroxycoumarin derivatives, Eur. J. Med. Chem., 41: 882-890.
35. S. Goodin, (2007), Oral chemotherapeutic agents: Understanding mechanisms of action and drug interactions Am. J Health-Syst. Pharm., 64 (Suppl 5): S15-24.
36. T. Yin and T. Miyata, (2007), Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - Rationale and perspectives Throm. Res., 120: 1-10.
37. V. Pengo, C. Pegoraro, U. Cucchini, S. Iliceto, (2006), Worldwide management of oral anti-coagulant therapy: the ISAM Study, J. Thromb. Thrombol., 21: 73-77.